PaperTrue

     恭喜清华大学电子工程系余佳东团队喜中ADVANCED MATERIALS(IF:25.8),购买服务为:优质润色 点击查看更多发表案例
以下是对 ANTICANCER RES 杂志介绍 收藏
缩写名/全名
ANTICANCER RES
ANTICANCER RESEARCH
ISSN号 0250-7005
研究方向 医学-肿瘤学
影响因子 2015:1.895, 2016:1.937, 2017:1.865, 2018:1.935, 2019:1.994,
出版国家 GREECE
出版周期 Bimonthly
年文章数 763
出版年份 1981
是否OA No
审稿周期(仅供参考) 平均2月
录用比例 约35%
投稿链接 http://www.iiar-submissions.com/login.html
投稿官网 http://ar.iiarjournals.org/
h-index 110
CiteScore
CiteScoreSJRSNIPCiteScore排名
1.900.7220.637
学科分区排名
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q3142 / 191
大类:Medicine
小类:Oncology
Q3192 / 321

PubMed Central (PMC)链接 http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0250-7005%5BISSN%5D
中科院SCI期刊分区
( 2018年新版本)
大类学科小类学科Top期刊综述期刊
医学 2区4区4区
ONCOLOGY
肿瘤学
4区3区4区
中科院SCI期刊分区
( 2020年新版本)
大类学科小类学科Top期刊综述期刊
医学 4区4区3区
ONCOLOGY
肿瘤学
3区2区4区
  • 该杂志上中国学者近期发表的论文
  • 同领域相关期刊
中国学者近期发表的论文
1.Etomidate Suppresses Invasion and Migration of Human A549 Lung Adenocarcinoma Cells.

Author: Chu CN1,2, Wu KC3,4, Chung WS5, Zheng LC6, Juan TK6, Hsiao YT6, Peng SF6, Yang JL6, Ma YS7,8, Wu RS9,10, Chung JG11,12.
Journal: Anticancer Res. 2019 Jan;39(1):215-223. doi: 10.21873/anticanres.13100.
    PubMed      DOI
2.Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier.

Author: Yuan BO1, Zhao Y2, Dong S2, Sun Y2, Hao F2, Xie J2, Teng L2, Lee RJ3,4, Fu Y5, Bi YE3,6.
Journal: Anticancer Res. 2019 Jan;39(1):237-243. doi: 10.21873/anticanres.13103.
    PubMed      DOI
3.Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose.

Author: Li CC1, Fang HY2,3, Lin CY4, Shen WC5, Chien CR6,3,7.
Journal: Anticancer Res. 2019 Jan;39(1):511-517. doi: 10.21873/anticanres.13142.
    PubMed      DOI
4.The C-Terminus of Hepatitis B Virus-encoded X Protein Is Required for Lapatinib Sensitivity in Hepatocellular Carcinoma Cells.

Author: Chen JY1,2, Huang WC1,2,3,4,5,6, Wei CT7,8, Chien PH9, Chen YJ10,9,11.
Journal: Anticancer Res. 2019 Feb;39(2):721-726. doi: 10.21873/anticanres.13168.
    PubMed      DOI
5.County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer.

Author: Li MU1, Gu S2, Mao R3, Ning Y1, Trivedi N4, Siddiqui A5, Li P1, Huo L6.
Journal: Anticancer Res. 2019 Feb;39(2):949-956. doi: 10.21873/anticanres.13198.
    PubMed      DOI
6.GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review.

Author: Syrjänen K1,2, Eskelinen M3, Peetsalu A4, Sillakivi T4, Sipponen P5, Härkönen M6, Paloheimo L7, Mäki M7, Tiusanen T7, Suovaniemi O6,7, DiMARIO F8, Fan ZP9.
Journal: Anticancer Res. 2019 Mar;39(3):1091-1104. doi: 10.21873/anticanres.13218.
    PubMed      DOI
7.β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization.

Author: Xu X1,2, Gao D2, Yuan X3, Liu LI2, Zhang X1, Liang X1, Chen S1,2, Ai M2, Chen BO2, Shi D2, Yang Z4, Hoffman RM4, Xu J5,2.
Journal: Anticancer Res. 2019 Mar;39(3):1129-1134. doi: 10.21873/anticanres.13221.
    PubMed      DOI
8.Targeted and Efficient Delivery of siRNA Using Tunable Polymeric Hybrid Micelles for Tumor Therapy.

Author: Hao F1, Dong S1, Yang C1, Li Z1, Cheng Z1, Zhong L1, Teng L1, Meng Q1, Lu J1, Wu F2, Xie J3, Teng L3, Lee RJ3,4.
Journal: Anticancer Res. 2019 Mar;39(3):1169-1178. doi: 10.21873/anticanres.13226.
    PubMed      DOI
9.Association of Matrix Metallopeptidase-2 Promoter Polymorphisms With the Risk of Childhood Leukemia.

Author: Hsu PC1, Pei JS1, Chen CC1, Chang WS2, Kuo CC3, Cheng SP4, Tsai CW5, Bau DT5,6,7, Gong CL8.
Journal: Anticancer Res. 2019 Mar;39(3):1185-1190. doi: 10.21873/anticanres.13228.
    PubMed      DOI
10.Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study.

Author: Cho BC1, DE Pas T2, Kalofonos H3, Wang Q4, Ramlau R5, Cheng Y6, Vitiello F7, Laisaar T8, Vallières E9, Kubisa B10, Orlov S11, Park K12, Debruyne C13, Vansteenkiste J14.
Journal: Anticancer Res. 2019 Mar;39(3):1403-1409. doi: 10.21873/anticanres.13255.
    PubMed      DOI
同类著名期刊名称 h-index CiteScore
CA-A CANCER JOURNAL FOR CLINICIANS144160.19
Nature Reviews Clinical Oncology1278.04
NATURE REVIEWS CANCER39623.23
LANCET ONCOLOGY27410.07
JOURNAL OF CLINICAL ONCOLOGY49411.08
CANCER CELL29515.04
ANNALS OF ONCOLOGY2108.44
SEMINARS IN CANCER BIOLOGY1348.86
CLINICAL CANCER RESEARCH2928.32
CANCER RESEARCH4116.94
中科院JCR同大类学科的热搜期刊 浏览次数
MEDICINE283219
CANCER RESEARCH163416
International Journal of Nanomedicine161787
Molecular Medicine Reports161566
CANCER LETTERS156850
JOURNAL OF ETHNOPHARMACOLOGY138689
BIOMEDICINE & PHARMACOTHERAPY136534
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY133301
Theranostics132486
International Journal of Environmental Research and Public Health130964